Jazz Pharmaceuticals CEO sells 2,000 shares
Jazz Pharmaceuticals CEO Gala Renee D sold 2,000 shares at $236.40 each, according to a Form 4 filing. The transaction was reported as part of a 10b5-1 plan.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.